Chun-Bing Chen Selected Research

Chun-Bing Chen Research Topics

Disease

14	Stevens-Johnson Syndrome (Lyell's Syndrome) 04/2024 - 01/2017
11	Hypersensitivity (Allergy) 05/2024 - 01/2018
11	Cicatrix (Scar) 04/2024 - 01/2018
7	Drug Hypersensitivity Syndrome 04/2024 - 01/2018
7	Neoplasms (Cancer) 12/2023 - 01/2018
5	Eosinophilia 01/2023 - 01/2018
5	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 01/2018
4	Inflammation (Inflammations) 04/2024 - 01/2019
4	Blister (Bulla) 10/2023 - 05/2017
4	Infections 02/2021 - 07/2015
4	Drug Hypersensitivity (Drug Allergy) 01/2021 - 01/2018
4	Exanthema (Rash) 01/2019 - 01/2018
3	Atopic Dermatitis (Atopic Eczema) 05/2024 - 10/2022
3	Pruritus (Itching) 10/2023 - 01/2022
3	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2023 - 01/2022
3	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2019
2	Mycoplasma Infections 12/2023 - 09/2022
2	Alopecia (Baldness) 10/2023 - 01/2019
2	Dermatitis 09/2023 - 02/2023
2	Wounds and Injuries (Trauma) 09/2022 - 01/2019
2	Gastrointestinal Hemorrhage (Hematochezia) 01/2022 - 01/2018
2	Fever (Fevers) 01/2022 - 01/2021
2	Necrosis 01/2018 - 08/2017
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 05/2024
1	Asthma (Bronchial Asthma) 05/2024
1	Vitamin D Deficiency 04/2024
1	Ovarian Neoplasms (Ovarian Cancer) 12/2023
1	Bullous Pemphigoid (Pemphigoid) 10/2023
1	Alopecia Areata 10/2023
1	COVID-19 10/2023
1	Perioral Dermatitis 09/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2023
1	Adenocarcinoma of Lung 02/2023
1	Mucositis 02/2023
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2023
1	Trichiasis 01/2023
1	Keloid 01/2023
1	Keratitis 01/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2023
1	Chronic Urticaria 01/2023
1	Leukopenia 11/2022
1	Exfoliative Dermatitis (Erythroderma) 11/2022
1	Psoriatic Arthritis 11/2022

Drug/Important Bio-Agent (IBA)

8	HLA-B Antigens (HLA-B)IBA 04/2024 - 01/2018
8	HLA Antigens (Human Leukocyte Antigens)IBA 04/2024 - 01/2018
6	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2021
5	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023 - 01/2018
5	Immune Checkpoint InhibitorsIBA 07/2023 - 10/2019
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2024 - 01/2018
4	COVID-19 VaccinesIBA 04/2024 - 11/2022
4	Etanercept (Enbrel)FDA Link 03/2024 - 01/2018
4	Immunosuppressive Agents (Immunosuppressants)IBA 10/2023 - 01/2018
4	CytokinesIBA 01/2022 - 05/2017
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 09/2023 - 02/2021
3	Tyrosine Kinase InhibitorsIBA 07/2023 - 02/2021
3	Allopurinol (Remid)FDA LinkGeneric 01/2023 - 01/2019
3	Interleukin-5 (Interleukin 5)IBA 01/2023 - 01/2019
3	ChemokinesIBA 01/2021 - 05/2017
3	Carbamazepine (Tegretol)FDA LinkGeneric 01/2020 - 01/2019
2	Immunoglobulin E (IgE)IBA 05/2024 - 01/2023
2	AllergensIBA 05/2024 - 04/2024
2	AntigensIBA 05/2024 - 01/2018
2	HLA-A Antigens (HLA-A)IBA 04/2024 - 01/2022
2	Peptides (Polypeptides)IBA 12/2023 - 01/2018
2	AutoantibodiesIBA 10/2023 - 01/2023
2	VaccinesIBA 10/2023 - 11/2022
2	ZincIBA 09/2023 - 02/2023
2	Genetic Markers (Genetic Marker)IBA 04/2023 - 01/2023
2	Interleukin-13IBA 01/2023 - 01/2022
2	SteroidsIBA 01/2023 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 09/2022 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 05/2017
2	Antineoplastic Agents (Antineoplastics)IBA 02/2021 - 01/2018
2	EnzymesIBA 01/2020 - 01/2018
2	HLA-B57 antigenIBA 01/2020 - 11/2019
1	brodalumabIBA 05/2024
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 05/2024
1	HLA-A*68 antigenIBA 04/2024
1	HLA-C Antigens (HLA-C)IBA 04/2024
1	Vitamin D FDA LinkGeneric 04/2024
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2023
1	Peptide Hydrolases (Proteases)FDA Link 10/2023
1	Excipients (Suspending Agents)IBA 10/2023
1	baricitinibIBA 09/2023
1	tocilizumab (atlizumab)FDA Link 09/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Collagenases (Collagenase)FDA Link 01/2023
1	Interleukin-4 (Interleukin 4)IBA 01/2023
1	Azathioprine (Imuran)FDA LinkGeneric 11/2022
1	mRNA VaccinesIBA 11/2022
1	dupilumabIBA 10/2022
1	Immunoglobulin A (IgA)IBA 10/2022

Therapy/Procedure

14	Therapeutics 12/2023 - 01/2018
5	Immunotherapy 05/2024 - 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2023